In mouse models of both diabetes types, AICAR prevented or reversed experimental diabetic peripheral neuropathy.
In plain wordsIn mice with either diabetes type, AICAR prevented or reversed diabetic nerve damage.
- Peptide
- AICAR (acadesine)
- Outcome
- DecreaseExperimental diabetic peripheral neuropathy
- Study
mousen: not reported in source
Mouse models of type 1 and type 2 diabetes- Outcome group
- Neuroprotection · Nervous system and cognition
- Studied dose
- Dose not stated
Source sentences
AICAR treatment prevented or reversed experimental DPN in mouse models of both T2D and T1D.
1 context sentence(design, population, supporting numbers)
We investigated the impact of an exercise mimetic, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), on DPN.